BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9882033)

  • 21. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily--a randomized, two-way crossover study.
    Miehlke S; Madisch A; Kirsch C; Lindner F; Kuhlisch E; Laass M; Knoth H; Morgner A; Labenz J
    Aliment Pharmacol Ther; 2005 Apr; 21(8):963-7. PubMed ID: 15813831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.
    Hartmann M; Theiss U; Huber R; Lühmann R; Bliesath H; Wurst W; Lücker PW
    Aliment Pharmacol Ther; 1996 Jun; 10(3):359-66. PubMed ID: 8791964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
    Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
    J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH.
    Täubel JJ; Sharma VK; Chiu YL; Lukasik NL; Pilmer BL; Pan WJ
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1807-17. PubMed ID: 11683695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
    Louw JA; van Rensburg CJ; Hanslo D; Grundlings HD; Girdwood AH; Marks IN
    Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
    Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
    Labenz J; Tillenburg B; Weismüller J; Lütke A; Stolte M
    Aliment Pharmacol Ther; 1997 Feb; 11(1):95-100. PubMed ID: 9042979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of duodenal ulcer with pantoprazole. A multicenter study].
    Fric P; Huslarová A; Dítĕ P; Jirásek V; Roth Z; Svoboda J; Drazná E; Dufek V; Dvorák M; Kunovská M; Münzová H; Pelech T; Petrtýl J; Zádorová Z; Zavoral M
    Cas Lek Cesk; 1996 Dec; 135(23):758-61. PubMed ID: 9005122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial.
    Avgerinos A; Sgouros S; Viazis N; Vlachogiannakos J; Papaxoinis K; Bergele C; Sklavos P; Raptis SA
    Scand J Gastroenterol; 2005 May; 40(5):515-22. PubMed ID: 16036503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
    Armstrong D; Bair D; James C; Tanser L; Escobedo S; Nevin K
    Aliment Pharmacol Ther; 2003 Oct; 18(7):705-11. PubMed ID: 14510744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acidity index: a simple approach to the measurement of gastric acidity.
    Tutuian R; Castell DO; Xue S; Katz PO
    Aliment Pharmacol Ther; 2004 Feb; 19(4):443-8. PubMed ID: 14871284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
    Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
    Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
    Cremer M; Lambert R; Lamers CB; Delle Fave G; Maier C
    Dig Dis Sci; 1995 Jun; 40(6):1360-4. PubMed ID: 7781461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole.
    Frazzoni M; De Micheli E; Grisendi A; Savarino V
    Aliment Pharmacol Ther; 2003 Jan; 17(2):235-41. PubMed ID: 12534408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
    Londong W
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH.
    Müssig S; Witzel L; Lühmann R; Schneider A
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):599-602. PubMed ID: 9222733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
    Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
    Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
    Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
    J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.